GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM80774
Query DataSets for GSM80774
Status
Public on Mar 30, 2006
Title
occipital_lobe_3
Sample type
RNA
Source name
occipital_lobe
Organism
Homo sapiens
Characteristics
Normal tissue
Extracted molecule
total RNA
Extraction protocol
Total RNA extracted using standard Trizol protocol, followed by Qiagen RNeasy column clean-up
Label
biotin
Label protocol
Approximately 5 µg of total RNA was processed to produce biotinylated cRNA targets.
Hybridization protocol
standard Affymetrix procedures
Scan protocol
standard Affymetrix procedures
Description
occipital_lobe_3
Data processing
RMA
Submission date
Oct 28, 2005
Last update date
Aug 28, 2018
Contact name
Richard B Roth
E-mail(s)
rroth@neurocrine.com
Organization name
Neurocrine Biosciences, Inc.
Department
Molecular Medicine
Street address
12790 El Camino Real
City
San Diego
State/province
CA
ZIP/Postal code
92130
Country
USA
Platform ID
GPL570
Series (1)
GSE3526
Comparison of gene expression profiles across the normal human body
Relations
Reanalyzed by
GSE64985
Reanalyzed by
GSE119087
Data table header descriptions
ID_REF
Affymetrix U133 plus 2.0 array
VALUE
RMA
Data table
ID_REF
VALUE
1007_s_at
710.0845
1053_at
42.123543
117_at
44.372047
121_at
201.44084
1255_g_at
15.337424
1294_at
71.57663
1316_at
88.18807
1320_at
27.830294
1405_i_at
12.584896
1431_at
37.20878
1438_at
80.76105
1487_at
116.125175
1494_f_at
60.899258
1552256_a_at
228.38127
1552257_a_at
115.87323
1552258_at
31.73098
1552261_at
37.8565
1552263_at
13.504833
1552264_a_at
86.77569
1552266_at
13.849171
Total number of rows:
54613
Table truncated, full table size
1090 Kbytes
.
Supplementary file
Size
Download
File type/resource
GSM80774.CEL.gz
8.1 Mb
(ftp)
(http)
CEL
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|
